evonetix is seeking to develop and commercialise a new approach to the synthesis of DNA.
Sign up today and learn more about evonetix Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About evonetix Stock
We are a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniques we are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.
Chief Technology Officer
Chief Scientific Officer